This statistic describes the global pharmaceutical sales in from 2016 to 2018, sorted by regional submarkets. As of Q3 2018, total pharmaceutical sales in the United States was estimated to reach around 464 billion U.S. dollars in that year.
World pharmaceutical sales by region
The pharmaceutical industry is best known for manufacturing pharmaceutical drugs which aim to diagnose, cure, treat, or prevent diseases. The pharmaceutical sector represents a huge industry, with the global market valuing in at nearly one trillion U.S. dollars. The best known top global pharmaceutical companies are Pfizer, Merck and Johnson & Johnson from the U.S., Novartis and Roche from Switzerland, Sanofi from France, etc. Accordingly, North America and Europe are still the largest global submarkets for pharmaceuticals.
In 2018, the United States was still the largest single pharmaceutical market, generating more than 460 billion U.S. dollars of revenue. Europe was responsible for generating around 196 billion U.S. dollars. These two markets, together with Japan, Canada and Australia, form the so-called established (or developed) markets. The rest of the global pharmaceutical revenue is mainly from emerging markets which include countries like China, Russia, Brazil and India. In fact, these emerging markets show the fastest increase in pharmaceutical sales. Non-EU European countries and the Indian Subcontinent are the only world regions for which compound annual growth rates of 10 percent or higher are predicted up until 2022.
World pharmaceutical sales by region
The pharmaceutical industry is best known for manufacturing pharmaceutical drugs which aim to diagnose, cure, treat, or prevent diseases. The pharmaceutical sector represents a huge industry, with the global market valuing in at nearly one trillion U.S. dollars. The best known top global pharmaceutical companies are Pfizer, Merck and Johnson & Johnson from the U.S., Novartis and Roche from Switzerland, Sanofi from France, etc. Accordingly, North America and Europe are still the largest global submarkets for pharmaceuticals.
In 2018, the United States was still the largest single pharmaceutical market, generating more than 460 billion U.S. dollars of revenue. Europe was responsible for generating around 196 billion U.S. dollars. These two markets, together with Japan, Canada and Australia, form the so-called established (or developed) markets. The rest of the global pharmaceutical revenue is mainly from emerging markets which include countries like China, Russia, Brazil and India. In fact, these emerging markets show the fastest increase in pharmaceutical sales. Non-EU European countries and the Indian Subcontinent are the only world regions for which compound annual growth rates of 10 percent or higher are predicted up until 2022.
